Kintsugi

We’re excited to introduce Haritha Haridas, PhD, who recently joined Kintsugi as our Clinical Strategy & Operations Director! Haritha brings extensive experience in clinical operations, having led large-scale SaMD clinical trials and driving innovation in digital health. Prior to Kintsugi, Haritha was a Clinical Operations Lead at Apple, where she played a key role in executing complex clinical trials. She holds a PhD in Biomedical Sciences and Biotechnology from the University of Udine in Italy and a Post-doctoral Professional Master’s in Bioscience Management from Keck Graduate Institute in California. Haritha’s expertise in clinical research, strategy, and operations will be instrumental in scaling our AI-driven mental health solutions, ensuring they are both impactful and clinically rigorous. We’re thrilled to have her on board! Join us in welcoming Haritha as she embarks on this new journey with Kintsugi! You can read more about Haritha’s background and what drew her to Kintsugi here: https://lnkd.in/eijzVJma

It was exciting to be in Las Vegas this week representing Northwell Health at the inaugural HumanX AI conference! I had the pleasure to take part in an insightful panel discussion with incredible tech visionaries Grace Chang (Founder & CEO at Kintsugi), Daniel Nathrath (CEO at Ada Health) and Elliott Green (CEO at Dandelion Health), moderated by Darrell Etherington (Founder at The Angle). We discussed some of the promising capabilities of AI in the #healthcare space and the impacts on access to the right care, at the right time, delivered with #empathy. #HumanX2025 #HumanExperience #PatientExperience (photo credit: Ross Harper🙏 )

✨ Exciting news from Inc. Magazine. Our Founder and CEO Grace Chang has been named to Inc.’s 2025 Female Founders list! 🎉 This annual list recognizes trailblazing women who are driving innovation that’s redefining industries. Grace’s leadership has propelled Kintsugi’s voice biomarker AI to the forefront of mental health technology – transforming the way we detect and support mental health conditions, and breaking down care barriers in the process. Congratulations Grace, and all the incredible Female Founders honored this year! 🚀

🚀 Kintsugi is in Las Vegas this week for the inaugural HumanX AI conference! Our Founder & CEO Grace Chang will be taking part in the panel discussion, “AI in healthcare: Delivering the right treatment, the first time,” on 3/12 at 11 AM (PT). She’ll be joining Sven Gierlinger (Chief Experience Officer at Northwell Health), Daniel Nathrath (CEO at Ada Health) and Elliott Green (CEO at Dandelion Health) and to explore how AI can bridge the gap between access and compassionate care. Let’s connect at hashtag #HumanX2025 – who else is here? 👋 #AI #MentalHealthTech #VoiceAI

Are you in Las Vegas for HIMSS? Want to see how our AI-powered tool detects signs and severity of depression by analyzing just 20 seconds of free-form speech? We’re giving a demo today at 1:15 PM – 2:15 PM at the Microsoft Pavilion (#2221, Venetian, Level 2). ✅ See Kintsugi Voice in action, including real-time voice screening for mental health conditions ✅ Discover how AI-powered voice biomarkers work ✅ Chat to our team to explore opportunities for collaboration Comment below or send us a message so we can connect! #HIMSS #MentalHealthTech #VoiceAI #MicrosoftPegasus

🚀 Heading to HIMSS? Come find us at the Microsoft Pavilion! We’re excited to showcase how voice biomarkers are shaping the future of mental health screening. Stop by (#2221, Venetian, Level 2) to see our AI-powered technology in action and chat with our team – including our newest team member, Dana Gusky, Director of Growth Strategy at Kintsugi. 🎉 Dana brings 10+ years of experience in AI-driven healthcare innovation, clinical decision support and go-to-market strategy – most recently leading business development for life sciences at Aidoc. We're thrilled to have her on board as we scale our impact in mental health tech! And finally, don’t miss Grace Chang, Founder & CEO of Kintsugi, speaking on the Women in Healthcare: Journeys of Leadership and Innovation panel today from 4-5 PM PT at the Microsoft Innovation Theater, alongside Amy Compton-Phillips, MD (Press Ganey) and Edwina Bhaskaran (Mayo Clinic). Let’s connect at #HIMSS25 and talk about the future of mental health innovation! Who’s going? 👋 #HIMSS #MentalHealthTech #VoiceAI #MicrosoftPegasus

The future of healthcare is being shaped by bold, innovative women – and we’re excited to be part of the conversation. Grace Chang, Founder & CEO of Kintsugi, will be speaking on the panel Women in Healthcare: Journeys of Leadership and Innovation at the 2025 HIMSS Global Health Conference & Exhibition in Las Vegas. 📍 Microsoft Innovation Theater 📅 Tuesday, March 4 | 4-5 PM PT Moderated by Kathleen Mitford of Global Industry at Microsoft, this panel brings together women leaders who are driving meaningful change in healthcare. Expect candid conversations on: 💡 Breaking barriers in healthtech 💡 Lessons from leadership & innovation 💡 Navigating challenges & driving impact The panel will be followed by a networking reception, where attendees can connect with executives and industry leaders. See you at #HIMSS25! #MSFTHealth #MicrosoftPartners #PartnersMakeMorePossible #AIInHealthcare #HealthcareOnLinkedIn

🌟 We’ve got exciting news! Kintsugi has been selected for Microsoft’s Pegasus Program. Among 80,000 startups in Microsoft’s global ecosystem, Kintsugi is one of just a few companies selected for the healthcare track, a recognition of our technology’s potential to reshape mental health care delivery. This partnership is a huge milestone for us as we work to scale our AI-powered voice biomarker platform, which enables early detection of depression and anxiety from as little as 20 seconds of speech. Through Pegasus, we’ll collaborate with Microsoft’s healthcare ecosystem to refine our technology, enhance integration with clinical workflows and expand our impact globally. Read more in our press release at the link below! https://lnkd.in/ePc3yuMb #MentalHealth #VoiceAI

Can AI detect depression from just 25 seconds of speech? Our new research published in The Annals of Family Medicine confirms that Kintsugi’s voice biomarker AI can identify moderate to severe depression with 71% sensitivity – compared to identification rates of just 47.3% in primary care. With depression affecting 21 million Americans each year, yet often going undiagnosed, this breakthrough could help bridge the gap in mental health screening – especially in primary care settings, where routine screening remains rare. AI-powered tools aren’t meant to replace clinical assessments, but they empower clinicians with real-time, objective insights, helping ensure patients get the support they need, when they need it. Read more in Inside Precision Medicine: https://lnkd.in/ezDYQ3zb

With AI as the topic du jour at #vive this week, Fast Company’s Victor Dey explores the evolving role of AI in emotional connection. Grateful to contribute my perspective on how voice AI can support mental health in meaningful ways. As we navigate this space, it’s critical to distinguish between AI as a tool for empowerment versus a replacement for human relationships. Excited to see where this conversation leads! #AI #MentalHealth #VoiceTech #FutureOfAI Full article: https://lnkd.in/gpYqTfHz